• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

艾塞那肽肽类

Exendin peptides.

作者信息

Eng J

机构信息

Solomon A. Berson Research Laboratory, Veterans Affairs Medical Center, Bronx, NY 10468.

出版信息

Mt Sinai J Med. 1992 Mar;59(2):147-9.

PMID:1574068
Abstract

Exendin-3 and exendin-4 are biologically active peptides isolated from venoms of the Gila monster lizards, H. horridum and H. suspectum, respectively. They were isolated using a chemical assay which detects peptides with amino-terminal histidine residues. Both are 39 amino acid peptides containing an amino-terminal histidine and a carboxyl-terminal serine amide and are members of the glucagon superfamily of peptide hormones. When tested in a dispersed pancreatic acinar cell assay, exendin-3 stimulates amylase release and with increasing concentrations causes a biphasic increase in cellular cAMP. In contrast, exendin-4 at concentrations up to 1 microM does not stimulate amylase release and produces a monophasic increase in cellular cAMP despite differing from exendin-3 by only two amino acid substitutions at positions 2 and 3 from the N-terminus. Endogenous Mammalian Analog to Exendins? The differences in biological activities can be explained by the observation that exendin-3 interacts with VIP receptors to stimulate amylase release, whereas exendin-4 does not. Both exendin-3 and exendin-4 interact with a putative exendin receptor on pancreatic acinar cells. The presence of this receptor was determined and defined by the ability of a specific inhibitor, exendin(9-39) amide, to abolish the increase in cAMP observed with 0.1-3 nM exendin-3 or exendin-4. The presence of the exendin receptor, although functionally undefined at the present time, predicts the existence of an endogenous mammalian analog to the exendin peptides.

摘要

艾塞那肽-3和艾塞那肽-4是分别从希拉毒蜥(Heloderma horridum)和可疑希拉毒蜥(Heloderma suspectum)毒液中分离出的生物活性肽。它们是通过一种化学检测方法分离出来的,该方法可检测具有氨基末端组氨酸残基的肽。两者都是由39个氨基酸组成的肽,含有一个氨基末端组氨酸和一个羧基末端丝氨酸酰胺,属于胰高血糖素肽激素超家族成员。在分散的胰腺腺泡细胞检测中,艾塞那肽-3能刺激淀粉酶释放,且随着浓度增加会导致细胞内cAMP呈双相增加。相比之下,浓度高达1微摩尔的艾塞那肽-4不刺激淀粉酶释放,尽管它与艾塞那肽-3仅在N端第2和第3位有两个氨基酸替换,但它会使细胞内cAMP呈单相增加。内源性哺乳动物艾塞那肽类似物?生物活性的差异可以通过以下观察来解释:艾塞那肽-3与血管活性肠肽(VIP)受体相互作用以刺激淀粉酶释放,而艾塞那肽-4则不然。艾塞那肽-3和艾塞那肽-4都与胰腺腺泡细胞上一种假定的艾塞那肽受体相互作用。这种受体的存在是通过一种特异性抑制剂艾塞那肽(9 - 39)酰胺消除0.1 - 3纳摩尔艾塞那肽-3或艾塞那肽-4所引起的cAMP增加的能力来确定和定义的。尽管目前艾塞那肽受体的功能尚不清楚,但其存在预示着存在一种内源性哺乳动物艾塞那肽肽类似物。

相似文献

1
Exendin peptides.艾塞那肽肽类
Mt Sinai J Med. 1992 Mar;59(2):147-9.
2
Isolation and characterization of exendin-4, an exendin-3 analogue, from Heloderma suspectum venom. Further evidence for an exendin receptor on dispersed acini from guinea pig pancreas.从希拉毒蜥毒液中分离并鉴定艾塞那肽-4(一种艾塞那肽-3类似物)。豚鼠胰腺分散腺泡存在艾塞那肽受体的进一步证据。
J Biol Chem. 1992 Apr 15;267(11):7402-5.
3
Purification and structure of exendin-3, a new pancreatic secretagogue isolated from Heloderma horridum venom.从毒蜥毒液中分离出的新型胰腺促分泌素艾塞那肽-3的纯化及结构
J Biol Chem. 1990 Nov 25;265(33):20259-62.
4
Origin and convergent evolution of exendin genes.Exendin 基因的起源和趋同进化。
Gen Comp Endocrinol. 2012 Jan 1;175(1):27-33. doi: 10.1016/j.ygcen.2011.11.025. Epub 2011 Nov 25.
5
Isolation and cloning of exendin precursor cDNAs from single samples of venom from the Mexican beaded lizard (Heloderma horridum) and the Gila monster (Heloderma suspectum).从墨西哥珠毒蜥(Heloderma horridum)和吉拉毒蜥(Heloderma suspectum)的单个毒液样本中分离并克隆艾塞那肽前体cDNA。
Toxicon. 2006 Mar;47(3):288-95. doi: 10.1016/j.toxicon.2005.11.004. Epub 2005 Dec 28.
6
Exendin-3, a novel peptide from Heloderma horridum venom, interacts with vasoactive intestinal peptide receptors and a newly described receptor on dispersed acini from guinea pig pancreas. Description of exendin-3(9-39) amide, a specific exendin receptor antagonist.艾塞那肽-3是一种来自毒蜥毒液的新型肽,它与血管活性肠肽受体以及豚鼠胰腺分散腺泡上一种新发现的受体相互作用。艾塞那肽-3(9-39)酰胺的描述,一种特异性艾塞那肽受体拮抗剂。
J Biol Chem. 1991 Feb 15;266(5):2897-902.
7
Molecular cloning of the helodermin and exendin-4 cDNAs in the lizard. Relationship to vasoactive intestinal polypeptide/pituitary adenylate cyclase activating polypeptide and glucagon-like peptide 1 and evidence against the existence of mammalian homologues.蜥蜴中helodermin和艾塞那肽-4 cDNA的分子克隆。与血管活性肠肽/垂体腺苷酸环化酶激活多肽及胰高血糖素样肽1的关系以及不存在哺乳动物同源物的证据。
J Biol Chem. 1998 Apr 17;273(16):9778-84. doi: 10.1074/jbc.273.16.9778.
8
Lack of effect of exendin-4 and glucagon-like peptide-1-(7,36)-amide on insulin action in non-diabetic humans.艾塞那肽-4和胰高血糖素样肽-1-(7,36)-酰胺对非糖尿病患者胰岛素作用无影响。
Diabetologia. 2002 Oct;45(10):1410-5. doi: 10.1007/s00125-002-0924-4. Epub 2002 Sep 5.
9
Truncated glucagon-like peptide-1 interacts with exendin receptors on dispersed acini from guinea pig pancreas. Identification of a mammalian analogue of the reptilian peptide exendin-4.截短的胰高血糖素样肽-1与豚鼠胰腺分散腺泡上的艾塞那肽受体相互作用。一种爬行动物肽艾塞那肽-4的哺乳动物类似物的鉴定。
J Biol Chem. 1992 Oct 25;267(30):21432-7.
10
Exendin-4, a new peptide from Heloderma suspectum venom, potentiates cholecystokinin-induced amylase release from rat pancreatic acini.艾塞那肽-4是一种来自可疑希拉毒蜥毒液的新型肽,它能增强胆囊收缩素诱导的大鼠胰腺腺泡淀粉酶释放。
Regul Pept. 1992 Sep 22;41(2):149-56. doi: 10.1016/0167-0115(92)90044-u.

引用本文的文献

1
Glucagon-Like Peptide-1 Links Ingestion, Homeostasis, and the Heart.胰高血糖素样肽-1与摄食、内环境稳态及心脏的联系。
Compr Physiol. 2025 Feb;15(1):e7. doi: 10.1002/cph4.7.
2
The discovery and development of GLP-1 based drugs that have revolutionized the treatment of obesity.GLP-1 类药物的发现和开发彻底改变了肥胖症的治疗方法。
Proc Natl Acad Sci U S A. 2024 Sep 24;121(39):e2415550121. doi: 10.1073/pnas.2415550121. Epub 2024 Sep 19.
3
Poly-Agonist Pharmacotherapies for Metabolic Diseases: Hopes and New Challenges.用于代谢性疾病的多激动剂药物疗法:希望与新挑战
Drugs. 2024 Feb;84(2):127-148. doi: 10.1007/s40265-023-01982-6. Epub 2023 Dec 21.
4
Mechanisms of action of incretin receptor based dual- and tri-agonists in pancreatic islets.基于肠促胰岛素受体的双重和三重激动剂在胰岛中的作用机制。
Am J Physiol Endocrinol Metab. 2023 Nov 1;325(5):E595-E609. doi: 10.1152/ajpendo.00236.2023. Epub 2023 Sep 20.
5
Neuroprotective Mechanisms of Glucagon-Like Peptide-1-Based Therapies in Ischemic Stroke: An Update Based on Preclinical Research.基于胰高血糖素样肽-1的疗法在缺血性卒中中的神经保护机制:基于临床前研究的最新进展
Front Neurol. 2022 Mar 15;13:844697. doi: 10.3389/fneur.2022.844697. eCollection 2022.
6
Glucagon-like peptide 1 (GLP-1).胰高血糖素样肽 1(GLP-1)。
Mol Metab. 2019 Dec;30:72-130. doi: 10.1016/j.molmet.2019.09.010. Epub 2019 Sep 30.
7
Exendin‑4 promotes osteogenic differentiation of adipose‑derived stem cells and facilitates bone repair.Exendin-4 促进脂肪来源干细胞的成骨分化并促进骨修复。
Mol Med Rep. 2019 Dec;20(6):4933-4942. doi: 10.3892/mmr.2019.10764. Epub 2019 Oct 23.
8
Molecular imaging of β-cells: diabetes and beyond.β细胞的分子影像学:糖尿病及其他。
Adv Drug Deliv Rev. 2019 Jan 15;139:16-31. doi: 10.1016/j.addr.2018.06.022. Epub 2018 Jul 3.
9
Dissecting the Physiology and Pathophysiology of Glucagon-Like Peptide-1.剖析胰高血糖素样肽-1的生理学和病理生理学
Front Endocrinol (Lausanne). 2018 Oct 11;9:584. doi: 10.3389/fendo.2018.00584. eCollection 2018.
10
Therapeutic effect of exendin-4, a long-acting analogue of glucagon-like peptide-1 receptor agonist, on nerve regeneration after the crush nerve injury.Exendin-4,一种长效胰高血糖素样肽-1 受体激动剂类似物,对挤压性神经损伤后神经再生的治疗效果。
Biomed Res Int. 2013;2013:315848. doi: 10.1155/2013/315848. Epub 2013 Aug 4.